Technical Analysis for MNK - Mallinckrodt plc

Grade Last Price % Change Price Change
grade B 21.9 0.37% 0.08
MNK closed up 0.37 percent on Thursday, July 19, 2018, on 74 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical MNK trend table...

Date Alert Name Type % Chg
Jul 19 Doji - Bearish? Reversal 0.00%
Jul 19 Overbought Stochastic Strength 0.00%
Jul 19 Up 3 Days in a Row Strength 0.00%
Jul 18 Overbought Stochastic Strength 0.37%
Jul 17 1,2,3 Pullback Bullish Bullish Swing Setup 1.34%
Jul 17 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 1.34%
Jul 17 NR7 Range Contraction 1.34%
Jul 17 Upper Bollinger Band Walk Strength 1.34%
Jul 17 Inside Day Range Contraction 1.34%
Jul 17 Overbought Stochastic Strength 1.34%

Older signals for MNK ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Mallinckrodt public limited company develops, manufactures, markets, and distributes branded and generic specialty pharmaceuticals, active pharmaceutical ingredients (API), and diagnostic imaging agents worldwide. The company's Specialty Pharmaceuticals segment offers EXALGO extended-release tablets to treat pain in opioid-tolerant patients; and GABLOFEN injections indicated for use in the management of spasticity of cerebral or spinal origin in patients age four years and above. This segment also provides generic drugs, such as oxycodone or in combination with acetaminophen, as well as hydrocodone, which in combination with acetaminophen to treat pain; and methylphenidate to treat attention deficit hyperactivity disorder. This segment markets its branded products to physicians, including pain specialists, anesthesiologists, orthopedic surgeons, rheumatologists, and neurologists; and generic products to wholesalers, large- and medium-sized retail pharmacy chains, food store chains with pharmacies, mail order pharmacies, and other channels of distribution. Its Global Medical Imaging segment provides contrast media and delivery systems comprising iodine- and gadolinium-containing injectable products for diagnostic imaging applications, such as computed tomography and magnetic resonance imaging under the Optiray and Optimark brand names. This segment also offers nuclear imaging agents consisting of Technescan MAG3, a nuclear imaging agent to detect and evaluate a range of renal disorders; technetium-99m for use in Ultra-Technekow DTE generators; cold kits; and other radiopharmaceuticals, such as Octreoscan to detect cancer. This segment sells its contrast media systems to hospitals and hospital groups; branded products directly to managed care organizations; and API products to other pharmaceutical companies. The company was incorporated in 2013 and is based in Dublin, Ireland. Mallinckrodt plc (NYSE:MNK) operates independently of Covidien plc as of June 28, 2013.
Is MNK a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 49.12
52 Week Low 11.65
Average Volume 3,075,177
200-Day Moving Average 20.1979
50-Day Moving Average 18.3854
20-Day Moving Average 20.1755
10-Day Moving Average 21.249
Average True Range 0.7621
ADX 36.8
+DI 31.1327
-DI 10.0497
Chandelier Exit (Long, 3 ATRs ) 19.8937
Chandelier Exit (Short, 3 ATRs ) 20.4863
Upper Bollinger Band 22.5168
Lower Bollinger Band 17.8342
Percent B (%b) 0.87
BandWidth 23.209338
MACD Line 0.996
MACD Signal Line 0.9094
MACD Histogram 0.0866
Fundamentals Value
Market Cap 2.13 Billion
Num Shares 97 Million
EPS -4.63
Price-to-Earnings (P/E) Ratio -4.73
Price-to-Sales 0.92
Price-to-Book 0.59
PEG Ratio 0.79
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 23.01
Resistance 3 (R3) 22.98 22.58 22.83
Resistance 2 (R2) 22.58 22.30 22.60 22.76
Resistance 1 (R1) 22.24 22.12 22.27 22.27 22.70
Pivot Point 21.84 21.84 21.86 21.86 21.84
Support 1 (S1) 21.50 21.56 21.53 21.53 21.10
Support 2 (S2) 21.10 21.38 21.12 21.04
Support 3 (S3) 20.76 21.10 20.98
Support 4 (S4) 20.79